Electronic Labeling Study By GAO Yields “No Consensus,” Avoids Cost Issue

In study mandated by FDASIA, GAO says there are advantages and disadvantages to switching to an electronic-only system for distributing drug label information, but offers no conclusions.

A Government Accountability Office report on electronic labeling did not appear to embolden either side in the debate over whether to do away with paper requirements.

The issue of cost, which likely would greatly affect decisions on whether to increase reliance on electronic labels, also was not addressed in the report,

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from United States

More from North America